Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study
暂无分享,去创建一个
Christer Halldin | Balázs Gulyás | Agneta Nordberg | Jenny Häggkvist | Ruiqing Ni | B. Gulyás | C. Halldin | A. Nordberg | E. Rodriguez-Vieitez | M. Tóth | Miklós Tóth | J. Häggkvist | R. Ni | L. Voytenko | A. Marutle | Elena Rodriguez-Vieitez | Amelia Marutle | Larysa Voytenko | Miklós Tóth
[1] Christer Halldin,et al. Detection of amyloid in Alzheimer’s disease with positron emission tomography using [11C]AZD2184 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[2] C. Rowe,et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study , 2013, The Lancet Neurology.
[3] Christer Halldin,et al. Performance Evaluation of the Small-Animal nanoScan PET/MRI System , 2013, The Journal of Nuclear Medicine.
[4] Mikio Shoji,et al. Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease , 2001, The Journal of Neuroscience.
[5] F. Saravia,et al. Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease , 2014, Hippocampus.
[6] E. Hol,et al. GFAP Isoforms in Adult Mouse Brain with a Focus on Neurogenic Astrocytes and Reactive Astrogliosis in Mouse Models of Alzheimer Disease , 2012, PloS one.
[7] M. Mattson. Pathways towards and away from Alzheimer's disease , 2004, Nature.
[8] G. Small,et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[9] B. Barres,et al. Astrocyte heterogeneity: an underappreciated topic in neurobiology , 2010, Current Opinion in Neurobiology.
[10] R. Coleman,et al. Use of florbetapir-PET for imaging beta-amyloid pathology. , 2011, JAMA.
[11] K. Blennow,et al. Characterization of the Brain β-Amyloid Isoform Pattern at Different Ages of Tg2576 Mice , 2011, Neurodegenerative Diseases.
[12] B. Gulyás,et al. Radiosynthesis of the candidate β‐amyloid radioligand [11C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys , 2010, Synapse.
[13] A. Nordberg. Molecular Imaging in Sporadic Alzheimer's Disease Populations and Those Genetically at Risk , 2014, Neurodegenerative Diseases.
[14] G. Miller. Neuroscience. The dark side of glia. , 2005, Science.
[15] K. Zahs,et al. Probing the Biology of Alzheimer's Disease in Mice , 2010, Neuron.
[16] L. Barré,et al. PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition , 2012, Neurobiology of Aging.
[17] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[18] Scott R. Barnum,et al. INFLAMMATION AND ALZHEIMERS DISEASE , 2000 .
[19] Christer Halldin,et al. Clinical Validation of 18F-AZD4694, an Amyloid-β–Specific PET Radioligand , 2012, The Journal of Nuclear Medicine.
[20] Stephen F. Carter,et al. Astrocytosis measured by 11C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer’s patients , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[21] S. DeKosky,et al. Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain , 2005, The Journal of Neuroscience.
[22] Michael V. Green,et al. PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[23] Stefan Platzer,et al. Small-Animal PET Imaging of Amyloid-Beta Plaques with [11C]PiB and Its Multi-Modal Validation in an APP/PS1 Mouse Model of Alzheimer's Disease , 2012, PloS one.
[24] M. Scheinin,et al. Longitudinal Amyloid Imaging in Mouse Brain with 11C-PIB: Comparison of APP23, Tg2576, and APPswe-PS1dE9 Mouse Models of Alzheimer Disease , 2013, The Journal of Nuclear Medicine.
[25] Milos Pekny,et al. The dual role of astrocyte activation and reactive gliosis , 2014, Neuroscience Letters.
[26] J. Trojanowski,et al. In Vivo Positron Emission Tomographic Imaging of Glial Responses to Amyloid-β and Tau Pathologies in Mouse Models of Alzheimer's Disease and Related Disorders , 2011, The Journal of Neuroscience.
[27] T. Wyss-Coray,et al. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. , 2003, Nature medicine.
[28] Kazuhiko Yanai,et al. 2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy)Benzoxazole: A Novel PET Agent for In Vivo Detection of Dense Amyloid Plaques in Alzheimer's Disease Patients , 2007, Journal of Nuclear Medicine.
[29] Pierre J Magistretti,et al. Amyloid-β Aggregates Cause Alterations of Astrocytic Metabolic Phenotype: Impact on Neuronal Viability , 2010, The Journal of Neuroscience.
[30] A. Nordberg,et al. 3H-Deprenyl and 3H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain , 2013, Journal of Neuroinflammation.
[31] M. Sofroniew,et al. Reactive Gliosis and the Multicellular Response to CNS Damage and Disease , 2014, Neuron.
[32] Andrew W. Kraft,et al. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] Y. Ao,et al. Heterogeneity of reactive astrocytes , 2014, Neuroscience Letters.
[34] P. Major,et al. National Electrical Manufacturers Association NU-4 Performance Evaluation of the PET Component of the NanoPET/CT Preclinical PET/CT Scanner , 2011, The Journal of Nuclear Medicine.
[35] Pedro Rosa-Neto,et al. MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research , 2014, Trends in Neurosciences.
[36] Agneta Nordberg,et al. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue. , 2013, Brain : a journal of neurology.
[37] C. D. Arnett,et al. Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. , 1987, Science.
[38] Alexei Verkhratsky,et al. Complex and region-specific changes in astroglial markers in the aging brain , 2014, Neurobiology of Aging.
[39] J. Growdon,et al. A phenotypic change but not proliferation underlies glial responses in Alzheimer disease. , 2013, The American journal of pathology.
[40] D. Thal. The role of astrocytes in amyloid β-protein toxicity and clearance , 2012, Experimental Neurology.
[41] P. Mcgeer,et al. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.
[42] Ove Almkvist,et al. Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG , 2012, The Journal of Nuclear Medicine.
[43] C. Halldin,et al. Quantitative localization of human brain monoamine oxidase B by large section autoradiography using l-[3H]deprenyl , 1991, Brain Research.
[44] E. Syková,et al. Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer’s disease , 2012, Journal of anatomy.
[45] P. Cumming,et al. Longitudinal Assessment of Cerebral β-Amyloid Deposition in Mice Overexpressing Swedish Mutant β-Amyloid Precursor Protein Using 18F-Florbetaben PET , 2013, The Journal of Nuclear Medicine.
[46] C. Rowe,et al. Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism , 2008, The Lancet Neurology.
[47] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[48] Agneta Nordberg,et al. Amyloid Imaging in Early Detection of Alzheimer’s Disease , 2010, Neurodegenerative Diseases.
[49] S. Younkin,et al. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[50] A. Verkhratsky,et al. Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease , 2011, ASN neuro.
[51] A. Nordberg,et al. Early changes in Aβ levels in the brain of APPswe transgenic mice—Implication on synaptic density, α7 neuronal nicotinic acetylcholine- and N-methyl-d-aspartate receptor levels , 2005, Molecular and Cellular Neuroscience.
[52] L. Zhou,et al. Amyloid-beta 25-35 peptide induces expression of monoamine oxidase B in cultured rat astrocytes. , 2000, Acta pharmacologica Sinica.
[53] A. Verkhratsky,et al. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease , 2010, Glia.
[54] J. Middeldorp,et al. Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease , 2014, Neurobiology of Aging.
[55] Bradley T. Hyman,et al. Brain Oligomeric &bgr;-Amyloid but Not Total Amyloid Plaque Burden Correlates With Neuronal Loss and Astrocyte Inflammatory Response in Amyloid Precursor Protein/Tau Transgenic Mice , 2011, Journal of neuropathology and experimental neurology.
[56] A. Rossi,et al. Cortical projection of putative group Ib afferent fibres from the human forearm , 1991, Brain Research.
[57] L. Thurfjell,et al. Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease , 2009, Journal of Nuclear Medicine.
[58] K. Moore,et al. Journal of Neuroinflammation BioMed Central , 2004 .
[59] B. Gulyás,et al. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-l-deprenyl using whole hemisphere autoradiography , 2011, Neurochemistry International.
[60] Lars Farde,et al. AZD2184: a radioligand for sensitive detection of β‐amyloid deposits , 2009, Journal of neurochemistry.
[61] Greg Miller,et al. The Dark Side of Glia , 2005, Science.
[62] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .